The Endocrine Society has selected five recipients for its Early Investigators Awards. The Early Investigators Awards were established to assist in the development of early-career investigators and to recognize their accomplishments in endocrine-related research. The Endocrine Society’s 2022 Early Investigators Award winners are: Omar Bello-Chavolla, MD, PhD, Instituto Nacional de Geriatría, Mexico City, Mexico –Bello-Chavolla...
Endocrine News talks with Christine M. Burt Solorzano, MD, chair of the committee that helped launch the Endocrine Society’s reinvigorated patient outreach program, EndoCares. With an in-person event taking place in Atlanta during ENDO 2022, EndoCares is set to become an important bridge between the Endocrine Society’s members and the patients they treat. The...
Shlomo Melmed, MB, ChB, the first recipient of the Transatlantic Alliance Award from the Endocrine Society and the European Society of Endocrinology (ESE) will be a featured speaker at ENDO 2022. Melmed’s talk, “Growth Hormone: An Adult Endocrine Misnomer,” will be featured in the Presidential Plenary, “Health Equity in Endocrinology” beginning at 2 p.m. on...
In anticipation of the Endocrine Society’s new open access journal, JCEM Case Reports, its editor-in-chief, William F. Young, Jr., MD, talks to Endocrine News about how this new journal will have a place for both master clinicians and early-career physicians to present their cases, why it’s important to hear the patient’s perspective, as well as...
Endocrine Society issues Scientific Statement to explain the endocrine roles of extracellular vesicles. In a new Scientific Statement released today, the Endocrine Society describes the importance of extracellular vesicles as a new research target for understanding the causes of certain endocrine disorders such as cancer and diabetes and discovering new treatments for these disorders. During...
Misinformation disregards science and restricts access to evidence-based care. The Endocrine Society objects to the Florida Department of Health’s bulletin on gender-affirming care for transgender and gender-diverse youth. The bulletin contradicts the U.S. Department of Health & Human Services’ resources and the Society’s own evidence-based Clinical Practice Guideline regarding gender-affirming care. We call on the Florida Department...
On Monday, February 21, the Texas attorney general issued a nonbinding legal opinion arguing that gender-affirming care falls under the state’s existing definition of child abuse and neglect. Following this, Texas Governor Greg Abbott released a directive ordering the Texas Department of Family and Protective Services (DFPS) to conduct investigations of any reported instances of...
Underlying problem of rising insulin prices still needs to be addressed. The Endocrine Society applauds the House of Representatives for hearing our call to improve insulin affordability for people with diabetes as it prepares to vote on the Affordable Insulin Now Act this week. The bill would cap patients’ out-of-pocket insulin costs to $35 per month for people on Medicare and private...